Third Pole Therapeutics

Heart and Lung Therapy Reimagined Navigation
  • Company
    • Overview
    • Our Team
    • Our Board of Directors
    • Our Scientific Advisors
    • Careers
    • Partnering
    • Policies
  • Investigational Devices
  • Company Press Releases
  • News/Publications
  • Contact
  • Company
    • Overview
    • Our Team
    • Our Board of Directors
    • Our Scientific Advisors
    • Careers
    • Partnering
    • Policies
  • Investigational Devices
  • Company Press Releases
  • News/Publications
  • Contact

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

  March 26, 2019   Company Press Releases

Third Pole Therapeutics, a privately held company developing and delivering transformative cardio-pulmonary therapies, announced today that it has entered into a strategic collaboration to work with Actelion Pharmaceuticals Ltd, a Janssen pharmaceutical company of Johnson & Johnson… 

  • Home
  • Company
  • Investigational Devices
  • Company Press Releases
  • News/Publications
  • Careers
  • Contact

© 2017-2019 Third Pole, Inc.